IL1B and neoplasm: The anticancer potential of the spiro-acridine compounds was associated with antiangiogenic action and up-regulation of Th1-type responses, mainly by inducing the increase of TNF-α and IL-1β levels in the tumor microenvironment (Duarte et al., 2020; Silva et al., 2020).